{"id":"https://openalex.org/W3148328959","doi":"https://doi.org/10.1186/s13148-021-01048-y","title":"Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples","display_name":"Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples","publication_year":2021,"publication_date":"2021-04-06","ids":{"openalex":"https://openalex.org/W3148328959","doi":"https://doi.org/10.1186/s13148-021-01048-y","mag":"3148328959","pmid":"https://pubmed.ncbi.nlm.nih.gov/33823933","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8025580"},"language":"en","primary_location":{"id":"doi:10.1186/s13148-021-01048-y","doi":"https://doi.org/10.1186/s13148-021-01048-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13148-021-01048-y","pdf_url":"https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-021-01048-y","source":{"id":"https://openalex.org/S200416800","display_name":"Clinical Epigenetics","issn_l":"1868-7075","issn":["1868-7075","1868-7083"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Epigenetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-021-01048-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087200653","display_name":"Jo\u00e3o Lobo","orcid":"https://orcid.org/0000-0001-6829-1391","observed_orcids":["https://orcid.org/0000-0001-6829-1391"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]},{"id":"https://openalex.org/I4405263123","display_name":"Instituto de Ci\u00eancias Biom\u00e9dicas Albel Salazar","ror":"https://ror.org/02trb6b02","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}],"countries":["NL","PT"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Lobo","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal","Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-6829-1391","affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]},{"raw_affiliation_string":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]},{"raw_affiliation_string":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038750132","display_name":"Vera Const\u00e2ncio","orcid":"https://orcid.org/0000-0002-3151-0367","observed_orcids":["https://orcid.org/0000-0002-3151-0367"]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Vera Const\u00e2ncio","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":"https://orcid.org/0000-0002-3151-0367","affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090585620","display_name":"Pedro Leite\u2010Silva","orcid":"https://orcid.org/0000-0001-7015-242X","observed_orcids":["https://orcid.org/0000-0001-7015-242X"]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Pedro Leite-Silva","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rita Guimar\u00e3es","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Rita Guimar\u00e3es","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059679783","display_name":"Mariana Cantante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Mariana Cantante","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017892303","display_name":"Isaac Campos Braga","orcid":"https://orcid.org/0000-0001-9265-4324","observed_orcids":["https://orcid.org/0000-0001-9265-4324"]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Isaac Braga","raw_affiliation_strings":["Department of Urology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":"https://orcid.org/0000-0001-9265-4324","affiliations":[{"raw_affiliation_string":"Department of Urology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049034018","display_name":"Joaquina Maur\u00edcio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Joaquina Maur\u00edcio","raw_affiliation_strings":["Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014887167","display_name":"Leendert H. J. Looijenga","orcid":"https://orcid.org/0000-0002-8146-1911","observed_orcids":["https://orcid.org/0000-0002-8146-1911"]},"institutions":[{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Leendert H. J. Looijenga","raw_affiliation_strings":["Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-8146-1911","affiliations":[{"raw_affiliation_string":"Princess M\u00e1xima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057879270","display_name":"Rui Henrique","orcid":"https://orcid.org/0000-0003-3171-4666","observed_orcids":["https://orcid.org/0000-0003-3171-4666"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]},{"id":"https://openalex.org/I4405263123","display_name":"Instituto de Ci\u00eancias Biom\u00e9dicas Albel Salazar","ror":"https://ror.org/02trb6b02","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Rui Henrique","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal. henrique@ipoporto.min-saude.pt","Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal. henrique@ipoporto.min-saude.pt","Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal. henrique@ipoporto.min-saude.pt","Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":"https://orcid.org/0000-0003-3171-4666","affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal. henrique@ipoporto.min-saude.pt","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]},{"raw_affiliation_string":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal. henrique@ipoporto.min-saude.pt","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal. henrique@ipoporto.min-saude.pt","institution_ids":["https://openalex.org/I4210111164"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042199157","display_name":"C\u00e1rmen Jer\u00f3nimo","orcid":"https://orcid.org/0000-0003-4186-5345","observed_orcids":["https://orcid.org/0000-0003-4186-5345"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]},{"id":"https://openalex.org/I4405263123","display_name":"Instituto de Ci\u00eancias Biom\u00e9dicas Albel Salazar","ror":"https://ror.org/02trb6b02","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Carmen Jer\u00f3nimo","raw_affiliation_strings":["Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt","Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt","Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal"],"raw_orcid":"https://orcid.org/0000-0003-4186-5345","affiliations":[{"raw_affiliation_string":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt","institution_ids":["https://openalex.org/I4210111164","https://openalex.org/I4405256639"]},{"raw_affiliation_string":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]},{"raw_affiliation_string":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513, Porto, Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5042199157","https://openalex.org/A5057879270"],"corresponding_institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4210111164","https://openalex.org/I4405256639","https://openalex.org/I4405263123"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":1.2613,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.78728564,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"13","issue":"1","first_page":"70","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11069","display_name":"Testicular diseases and treatments","score":0.09769999980926514,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/testicular-germ-cell-tumors","display_name":"testicular germ cell tumors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/promoter-hypermethylation","display_name":"promoter hypermethylation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.40400001406669617},{"id":"https://openalex.org/keywords/embryonal-carcinoma","display_name":"embryonal carcinoma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7889999747276306},{"id":"https://openalex.org/keywords/immune-microenvironment","display_name":"immune microenvironment","score":0.7490000128746033},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9440000057220459},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/chromatin-remodeling","display_name":"chromatin remodeling","score":0.7649999856948853},{"id":"https://openalex.org/keywords/histological-subtypes","display_name":"histological subtypes","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.695046603679657},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5493474006652832},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.5391713380813599},{"id":"https://openalex.org/C115519274","wikidata":"https://www.wikidata.org/wiki/Q267903","display_name":"EPIC","level":2,"score":0.4941451847553253},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49319595098495483},{"id":"https://openalex.org/C2779122487","wikidata":"https://www.wikidata.org/wiki/Q281579","display_name":"Germ cell","level":3,"score":0.4859291613101959},{"id":"https://openalex.org/C47042493","wikidata":"https://www.wikidata.org/wiki/Q265799","display_name":"Human genetics","level":3,"score":0.46444064378738403},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.43890613317489624},{"id":"https://openalex.org/C2776938808","wikidata":"https://www.wikidata.org/wiki/Q1737977","display_name":"Germ cell tumors","level":3,"score":0.4208885133266449},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3988339602947235},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34557121992111206},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3288036286830902},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.24444949626922607},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16295963525772095},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1383289396762848},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13334336876869202},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.09239265322685242},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009373","descriptor_name":"Neoplasms, Germ Cell and Embryonal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009373","descriptor_name":"Neoplasms, Germ Cell and Embryonal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D013736","descriptor_name":"Testicular Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013736","descriptor_name":"Testicular Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1186/s13148-021-01048-y","doi":"https://doi.org/10.1186/s13148-021-01048-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13148-021-01048-y","pdf_url":"https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-021-01048-y","source":{"id":"https://openalex.org/S200416800","display_name":"Clinical Epigenetics","issn_l":"1868-7075","issn":["1868-7075","1868-7083"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Epigenetics","raw_type":"journal-article"},{"id":"pmid:33823933","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33823933","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical epigenetics","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:8025580","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8025580/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Epigenetics","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/s13148-021-01048-y","doi":"https://doi.org/10.1186/s13148-021-01048-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13148-021-01048-y","pdf_url":"https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-021-01048-y","source":{"id":"https://openalex.org/S200416800","display_name":"Clinical Epigenetics","issn_l":"1868-7075","issn":["1868-7075","1868-7083"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Epigenetics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1745330444","display_name":"DESENVOLVIMENTO DE NOVOS BIOMARCADORES EPIGEN\u00c9TICOS PROGN\u00d3STICOS E PREDITIVOS PARA TUMORES MALIGNOS DE C\u00c9LULAS GERMINATIVAS TESTICULARES","funder_award_id":"PTDC/MEC-URO/29043/2017","funder_id":"https://openalex.org/F4320334779","funder_display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia"},{"id":"https://openalex.org/G2188530478","display_name":null,"funder_award_id":"PTDC/MECONC/ 29043/2017","funder_id":"https://openalex.org/F4320334779","funder_display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia"},{"id":"https://openalex.org/G4691414631","display_name":"Uncovering novel prognostic and predictive epigenetic biomarkers in malignant testicular germ cell tumors","funder_award_id":"SFRH/BD/132751/2017","funder_id":"https://openalex.org/F4320334779","funder_display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia"},{"id":"https://openalex.org/G5454278309","display_name":null,"funder_award_id":"/2017","funder_id":"https://openalex.org/F4320334779","funder_display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia"}],"funders":[{"id":"https://openalex.org/F4320321837","display_name":"Ministerio de Econom\u00eda y Competitividad","ror":"https://ror.org/034900433"},{"id":"https://openalex.org/F4320323642","display_name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","ror":"https://ror.org/045b9pr88"},{"id":"https://openalex.org/F4320327240","display_name":"Liga Portuguesa Contra o Cancro","ror":"https://ror.org/03r31ar10"},{"id":"https://openalex.org/F4320334779","display_name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","ror":"https://ror.org/00snfqn58"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3148328959.pdf","grobid_xml":"https://content.openalex.org/works/W3148328959.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1987941144","https://openalex.org/W1991422670","https://openalex.org/W2057882999","https://openalex.org/W2074159076","https://openalex.org/W2097906111","https://openalex.org/W2112797367","https://openalex.org/W2128292637","https://openalex.org/W2148859095","https://openalex.org/W2165400010","https://openalex.org/W2168789589","https://openalex.org/W2182472818","https://openalex.org/W2236154090","https://openalex.org/W2483690177","https://openalex.org/W2534544939","https://openalex.org/W2549852019","https://openalex.org/W2560067501","https://openalex.org/W2765537501","https://openalex.org/W2807733000","https://openalex.org/W2883118933","https://openalex.org/W2883621554","https://openalex.org/W2886615577","https://openalex.org/W2892340405","https://openalex.org/W2892469234","https://openalex.org/W2904463647","https://openalex.org/W2905688234","https://openalex.org/W2906455024","https://openalex.org/W2909659679","https://openalex.org/W2912699041","https://openalex.org/W2914177134","https://openalex.org/W2915685079","https://openalex.org/W2922074090","https://openalex.org/W2938759794","https://openalex.org/W2947584913","https://openalex.org/W2948259955","https://openalex.org/W2952821257","https://openalex.org/W2954139191","https://openalex.org/W2967416620","https://openalex.org/W2971532743","https://openalex.org/W2979880332","https://openalex.org/W2994739107","https://openalex.org/W2999824625","https://openalex.org/W3003753655","https://openalex.org/W3009302416","https://openalex.org/W3010468069","https://openalex.org/W3020851428","https://openalex.org/W3034493637","https://openalex.org/W3047355154","https://openalex.org/W3095446721","https://openalex.org/W3096629759","https://openalex.org/W3097796869","https://openalex.org/W3113672448"],"related_works":["https://openalex.org/W6920850252","https://openalex.org/W6958551589","https://openalex.org/W6920754891","https://openalex.org/W6958857000","https://openalex.org/W3096629759","https://openalex.org/W3178121257","https://openalex.org/W3196987569","https://openalex.org/W2954139191","https://openalex.org/W4367052175","https://openalex.org/W2948259955"],"abstract_inverted_index":{"Testicular":[0],"germ":[1],"cell":[2,157],"tumors":[3],"(TGCTs)":[4],"are":[5,57],"among":[6,162],"the":[7,75,100,122,132,142,216],"most":[8,17],"common":[9],"solid":[10],"malignancies":[11],"in":[12,110,121,172,229],"young-adult":[13],"men,":[14],"and":[15,24,53,69,117,127,154,197,209,233],"currently":[16],"mortality":[18],"is":[19,31,37],"due":[20],"to":[21,28,88,90,131,137,192,206],"metastatic":[22,54,70],"disease":[23,126],"emergence":[25],"of":[26,66,78,85,97,145,152,164,180,185,194,199,218],"resistance":[27],"cisplatin.":[29],"There":[30],"some":[32,83],"evidence":[33],"that":[34],"increased":[35],"methylation":[36,80,112],"one":[38],"mechanism":[39],"behind":[40],"this":[41],"resistance,":[42],"stemming":[43],"from":[44],"individual":[45],"studies,":[46],"but":[47,82,225],"approaches":[48],"based":[49],"on":[50,149,189,203],"matched":[51,67],"primary":[52,68],"patient":[55,123,133,173],"samples":[56,86,165,182],"lacking.":[58],"Herein,":[59],"we":[60],"provide":[61],"an":[62],"EPIC":[63],"array-based":[64],"study":[65,147],"TGCT":[71,156],"samples.":[72,175],"Histology":[73],"was":[74,92],"major":[76],"determinant":[77],"overall":[79],"pattern,":[81],"clustering":[84],"related":[87,191,205],"response":[89,136],"cisplatin":[91],"observed.":[93],"Further":[94],"differential":[95],"analysis":[96,179],"patients":[98],"with":[99,124,134,231],"same":[101],"histological":[102],"subtype":[103],"(embryonal":[104],"carcinoma)":[105],"disclosed":[106],"a":[107],"remarkable":[108],"increase":[109],"net":[111],"levels":[113],"(at":[114],"both":[115],"promoter":[116],"CpG":[118],"site":[119],"level)":[120],"cisplatin-resistant":[125,181,223],"poor":[128],"outcome":[129],"compared":[130],"complete":[135],"chemotherapy.":[138],"This":[139,211],"further":[140],"confirms":[141],"recent":[143],"results":[144],"another":[146],"performed":[148],"isogenic":[150],"clones":[151],"sensitive":[153],"resistant":[155],"lines.":[158],"Differentially":[159],"methylated":[160],"promoters":[161,188,202],"groups":[163],"were":[166],"mostly":[167],"not":[168,214],"shared,":[169],"disclosing":[170],"heterogeneity":[171],"tissue":[174],"Finally,":[176],"gene":[177],"ontology":[178],"indicated":[183],"enrichment":[184,198],"differentially":[186,200],"hypermethylated":[187],"pathways":[190,204],"regulation":[193],"immune":[195],"microenvironment,":[196],"hypomethylated":[201],"DNA/chromatin":[207],"binding":[208],"regulation.":[210],"data":[212],"supports":[213],"only":[215],"use":[217,228],"hypomethylating":[219],"agents":[220],"for":[221],"targeting":[222],"disease,":[224],"also":[226],"their":[227],"combination":[230],"immunotherapies":[232],"chromatin":[234],"remodelers.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-04-13T00:00:00"}